Mark William Nachtigal (Mark W Nachtigal)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Squamous Cell Carcinoma

Top Venues

Current oncology (Toronto, Ont.)

RNA (New York, N.Y.)

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Evan Paul Booy, Daniel Gussakovsky, Mira Jf Brown, Rowan Shwaluk, Mark William Nachtigal, Sean A McKenna
lncRNA BC200 is processed into a stable Alu monomer. RNA (New York, N.Y.) (2024)
Lesley F Roberts, Pascal Lambert, Mark William Nachtigal, Alon D Altman, Erin Dean
Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Lesley F Roberts, Pascal Lambert, Mark William Nachtigal, Alon D Altman, Erin Dean
Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Lesley F Roberts, Pascal Lambert, Mark William Nachtigal, Alon D Altman, Erin Dean
Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Lesley F Roberts, Pascal Lambert, Mark William Nachtigal, Alon D Altman, Erin Dean
Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Selina Casalino, Sharon Bruce, Kim Serfas, Alon D Altman, Sarah Kean, Pascal Lambert, Kirk James McManus, Jessica N Hartley, Mark William Nachtigal
Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: A mixed-methods study. Journal of genetic counseling (2023)
Kelcey Winchar, Pascal Lambert, Kirk James McManus, Bernie Chodirker, Sarah Kean, Kim Serfas, Kathleen Margaret Decker, Mark William Nachtigal, Alon D Altman
Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019. Current oncology (Toronto, Ont.) 29 (12) (2022)
Kelcey Winchar, Pascal Lambert, Kirk James McManus, Bernie Chodirker, Sarah Kean, Kim Serfas, Kathleen Margaret Decker, Mark William Nachtigal, Alon D Altman
Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019. Current oncology (Toronto, Ont.) 29 (12) (2022)
Kelcey Winchar, Pascal Lambert, Kirk James McManus, Bernie Chodirker, Sarah Kean, Kim Serfas, Kathleen Margaret Decker, Mark William Nachtigal, Alon D Altman
Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019. Current oncology (Toronto, Ont.) 29 (12) (2022)
Kelcey Winchar, Pascal Lambert, Kirk James McManus, Bernie Chodirker, Sarah Kean, Kim Serfas, Kathleen Margaret Decker, Mark William Nachtigal, Alon D Altman
Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019. Current oncology (Toronto, Ont.) 29 (12) (2022)
Mark William Nachtigal, Alon D Altman, Rajat Arora, Frank Schweizer, Gilbert Arthur
The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer. Cancers 14 (14) (2022)
Kelcey Winchar, Pascal Lambert, Kirk James McManus, Bernie Chodirker, Sarah Kean, Kim Serfas, Kathleen Margaret Decker, Mark William Nachtigal, Alon D Altman
Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019. Current oncology (Toronto, Ont.) 29 (12) (2022)
Jerry Vriend, Mark William Nachtigal
Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer. Cancers 13 (11) (2021)
Chloe Camille Lepage, Michaela Cora Lynn Palmer, Ally Catherina Farrell, Nicole Marie Neudorf, Zelda Lichtensztejn, Mark William Nachtigal, Kirk James McManus
Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer. British journal of cancer 124 (10) (2021)
Signe Penner-Goeke, Zelda Lichtensztejn, Megan Neufeld, Jennifer L Ali, Alon D Altman, Mark William Nachtigal, Kirk J McManus
The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples. PLoS genetics 13 (4) (2017)